Univariate analysis revealed that low SOX6 expression (P < 0.001), poor differentiation (P < 0.001), lymph node metastasis (P < 0.001) and late disease stage (P < 0.001) were significant prognostic factors (Table 2). Here, SOX6 is linked to metastatic malignant neoplasm in the lymph nodes.